Biogen Idec partners with WPI for biomanufacturing training; Ranbaxy aims to restore faith with key customers;

> Biogen Idec ($BIIB) has collaborated with Worchester Polytechnic Institute on biomanufacturing training for employees of the biotech giant. WPI's corporate partners also work on non-proprietary training. Item

> Drugmaker Ranbaxy has sought meetings with major hospitals in India after agreeing to pay $500 million in penalties to U.S. authorities for multiple violations. Report

> Large quantities of easily-accesible counterfeit malaria drugs in Angola don't contain the active ingredient in antimalarials. This could reverse years of headway in fighting the disease, experts say. Article

> China's Sun Pharmaceutical is negotiating a deal to build a plant in Lahore, to manufacture infusion drugs for Pakistan's Medipak Ltd. Report

> Main Street Family Pharmacy is voluntarily recalling all of its sterile injectable drugs after 7 reports of adverse reactions in patients who received injections of preservative-free methylprednisolone acetate, manufactured Newbern, TN, compounder. Article

And Finally... The President's Emergency Plan for AIDS Relief (PEPFAR) has worked with U.S. implementing agencies, international donors and partner countries to increase the efficiency and reliability of antiretroviral (ARV) drug supply chains. It has done so by improving drug supply planning and procurement as well as incountry distribution of drugs. Report